2006-2008

Alcon CMS-06-12, SAFETY AND EFFICACY OF SWITCHING TO THE TRAVOPROST/TIMOLOL MALEATE FIXED COMBINATION (DUOTRAV) FROM PRIOR MONO- OR TWO-DRUG THERAPY IN GERMANY.

2007-2009

PRN 06-010, LONG-TERM RETROSPECTIVE ECONOMIC, EFFICACY AND SAFETY ANALYSIS OF LATANOPROST 0.005% VERSUS TIMOLOL MALEATE 0.5% IN PATIENTS WITH PRIMARY OPEN-ANGLE GLAUCOMA IN EUROPE

2009-2010

Alcon SMA 08-010, Diurnal IOP-lowering Efficacy and Safety of Travoprost 0.004% vs. Tafluprost 0.0015% in Subjects with Primary Open-Angle Glaucoma or Ocular Hypertension    

2010

Alcon RDG-10-243, Assessing the Safety and Efficacy of Changing to DuoTrav® (Travoprost 0,004%/Timolol 0,5% Fixed Combination), as Replacement Therapy in Patients Uncontrolled on Bimatoprost 0,03%/Timolol 0,5% Therapy (Fixed or Unfixed)

2012

Alcon RDG-10-251, Patient Preference Comparison of AZARGA versus COSOPT, in Patients with Open-Angle Glaucoma or Ocular Hypertension

2012

Alcon RDG-10-272, Assessing the Efficacy and Tolerability of Changing to DuoTrav® (Travoprost 0,004%/Timolol 0,5% Fixed Combination), as Replacement Therapy in Patients Previously on Bimatoprost 0,03%/Timolol 0,5% Therapy (Fixed or Unfixed)